re: Ann: Notice of Annual General Meeting/Pro... I agree with you Stagman and Doogsie. The number of options is well out of proportion to the performance. Also, the option price of 30% above market is well short of where the true value of the shares should lie - if you believe Ian Finch (and I certainly do !)The proposal is also poorly timed, just when the company needs to attract more capital. Investors are universally sick of this self-serving attitude by directors and such actions are enough to put many people off a small cap newbie company like this. I will be voting against the resolutions and urge other s.holders to do the same. I have no objection to rewarding directors for their achievements but the reward has got to be in proportion.
- Forums
- ASX - By Stock
- TRF
- Ann: Notice of Annual General Meeting/Proxy Form
Ann: Notice of Annual General Meeting/Proxy Form , page-10
-
- There are more pages in this discussion • 28 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TRF (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online